BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 23737033)

  • 1. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
    Lara LA; Cartagena-Ramos D; Figueiredo JB; Rosa-E-Silva ACJ; Ferriani RA; Martins WP; Fuentealba-Torres M
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD009672. PubMed ID: 37619252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
    Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-back therapy with GnRH analogues for uterine fibroids.
    Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture for menopausal hot flushes.
    Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioidentical hormones for women with vasomotor symptoms.
    Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise for vasomotor menopausal symptoms.
    Daley A; Stokes-Lampard H; Thomas A; MacArthur C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006108. PubMed ID: 25431132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective oestrogen receptor modulators (SERMs) for endometriosis.
    van Hoesel MH; Chen YL; Zheng A; Wan Q; Mourad SM
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011169. PubMed ID: 33973648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black cohosh (Cimicifuga spp.) for menopausal symptoms.
    Leach MJ; Moore V
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update.
    Meziou N; Scholfield C; Taylor CA; Armstrong HL
    Menopause; 2023 Jun; 30(6):659-671. PubMed ID: 37159867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar C; Marjoribanks J; Lethaby A; Suckling JA; Lamberts Q
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004143. PubMed ID: 19370593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
    Ismail SI; Bain C; Hagen S
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.